UniProtKB/Swiss-Prot P63000: Variant p.Val182Glu

• Variant information
• Sequence information
• Literature citations
• All

Variant information

Variant position: 182 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: LB/B The variants are classified into three categories: LP/P, LB/B and US.

• LP/P: likely pathogenic or pathogenic.
• LB/B: likely benign or benign.
• US: uncertain significance

Residue change: From Valine (V) to Glutamate (E) at position 182 (V182E, p.Val182Glu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: Change from medium size and hydrophobic (V) to medium size and acidic (E) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

• Lowest score: -4 (low probability of substitution).
• Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources: Links to websites of interest for the variant.

• Variant rs5836 [ dbSNP | Ensembl ]

Sequence information

Variant position: 182 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 192 The length of the canonical sequence.
Location on the sequence: QRGLKTVFDEAIRAVLCPPP V KKRKRKCLLL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

• Type: the type of sequence feature.
• Positions: endpoints of the sequence feature.
• Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 189	Ras-related C3 botulinum toxin substrate 1
Motif	179 – 188	Polybasic region; required for nuclear import
Modified residue	189 – 189	Cysteine methyl ester
Lipidation	183 – 183	(Microbial infection) N6-palmitoyl lysine
Lipidation	184 – 184	(Microbial infection) N6-palmitoyl lysine
Lipidation	189 – 189	S-geranylgeranyl cysteine
Cross	166 – 166	Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
Mutagenesis	166 – 166	K -> R. Loss of FBXL19-induced polyubiquitination.
Mutagenesis	183 – 183	K -> A. Slightly decreased palmitoylation by the V.cholerae toxin RtxA.
Mutagenesis	184 – 184	K -> A. Slightly decreased palmitoylation by the V.cholerae toxin RtxA.
Mutagenesis	186 – 186	K -> A. Decreased palmitoylation by the V.cholerae toxin RtxA.
Mutagenesis	188 – 188	K -> A. Decreased palmitoylation by the V.cholerae toxin RtxA.

Literature citations

No reference for the current variant in UniProtKB/Swiss-Prot.